Clinical Trials

Study Title:
A Phase 1b Dose Optimization Study of Sovilnesib (An Oral KIF18A Inhibitor) in Subjects with Advanced High Grade Serous Ovarian Cancer

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Brian Orr, at orrb@musc.edu.
Study Coordinator, Crystal Knox, at knoxc@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina